A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts
Condition(s):Previously Treated Primary Immune ThrombocytopeniaLast Updated:February 29, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Previously Treated Primary Immune ThrombocytopeniaLast Updated:February 29, 2024Active, not recruiting
Condition(s):Anemia, AplasticLast Updated:February 12, 2024Not yet recruiting
Condition(s):Primary Immune ThrombocytopeniaLast Updated:November 15, 2019Unknown status
Condition(s):ThrombocytopeniaLast Updated:October 30, 2018Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:February 28, 2022Recruiting
Condition(s):Liver Disease Chronic; ThrombocytopeniaLast Updated:January 14, 2022Unknown status
Condition(s):Cancer Treatment Induced ThrombocytopeniaLast Updated:March 1, 2024Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:September 1, 2020Unknown status
Condition(s):Immune Thrombocytopenia; PregnancyLast Updated:April 20, 2016Unknown status
Condition(s):Immune ThrombocytopeniaLast Updated:September 1, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.